The cost-effectiveness of terazosin and placebo in the treatment of moderate to severe benign prostatic hyperplasia

Alan L. Hillman, J. Sanford Schwartz, Mary Kaye Willian, Ellen Peskin, Claus Roehrborn, Joseph E. Oesterling, Michael F. Mason, Clem J. Maurath, Patricia A. Deverka, Robert J. Padley

Research output: Contribution to journalArticle

27 Scopus citations

Fingerprint Dive into the research topics of 'The cost-effectiveness of terazosin and placebo in the treatment of moderate to severe benign prostatic hyperplasia'. Together they form a unique fingerprint.

Medicine & Life Sciences